Search

The EU’s new funding plan promises a big drop in paperwork and bureaucracy for grant applicants and recipients - but the details will matter

A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission’s plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth – but is it too expensive?

In the US as in Europe, competition regulators are stepping up efforts to prevent pharmaceutical companies blocking the sale of generics

Investments in ehealth can pay off for patients and healthcare administrators, as a growing number of systems across Europe testify. Now is not the time to cut back on investment

The promise of accelerated approvals and higher pricing has persuaded pharmaceutical companies to break the deadlock in antibiotic R&D

Entrepreneurship is the route to growth and job creation. But don’t try and kid Europe’s unemployed youth they can all be entrepreneurs.

WIPO report highlights how intellectual property is moving from being a purely technical issue to become a central part of innovation policy

ARTEMIS has shown it is possible to take a broadly-applicable technology and develop it to meet the needs of different industries and different countries. There are lessons here for other cross-industry initiatives

Spurred by the seminal report of Esko Aho, in 2007 the EU set about trying to use its massive public sector spending power to create a coordinated demand for new products. A report on the Lead Market Initiative considers the progress of the policy to date